|
|
|
|
|
|
|
20.02.26 - 13:33
|
Harvest High Income Shares ETFs Announces February 2026 Distributions (Business Wire)
|
|
|
OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest High Income Shares ETFs TM for the month ending February 28, 2026. The distribution will be paid on or about March 6, 2026 to securityholders of record on February 27, 2026 with an ex-dividend date of February 27, 2026.
Harvest High Income Shares ETF
TSX Ticker
Distribution
Harvest Eli Lilly High Income Shares ETF
LLYH
$0.1500 per unit
Harvest Eli Lilly High Income Shares ETF (US)
LLYH.U
$0.1500 per unit
Harvest Amazon High Income Shares ETF
AMZH
$0.1400 per unit
Harvest Amazon High Income Shares ETF (US)
AMZH.U
$0.1400 per unit
Harvest Microsoft High Income Shares ETF
MSFH
$0.1400 per unit
Harvest Microsoft High Income Shares ETF (US)
MSFH.U
$0.1400 per unit
Harvest NVIDIA High Income Shares ETF
NVDH
$0.2000 per unit
Harvest NVIDIA High Income Shares ETF (US)
NVDH.U
$0.1900 per unit
Harvest Eli Lilly Enhanced High Income Shares ETF
LLHE
$0.1650 per unit
Harvest Eli Lilly Enh...
|
|
|
|
|
20.02.26 - 12:42
|
Eli Lilly Aktie: GLP-1-Boom - kommt jetzt die nächste Bewertungswelle? (Aktiencheck)
|
|
|
London (www.aktiencheck.de) - Eli Lilly-Aktienanalyse von Barclays:
Barclays habe die Coverage der Aktie von Eli Lilly and Company (ISIN: US5324571083, WKN: 858560, Ticker-Symbol: LLY, NYSE-Symbol: LLY) mit einem "overweight"-Rating und einem Kursziel von 1.350 USD aufgenommen. Die Bank sehe GLP-1-Abnehmtherapien als einen dauerhaften strukturellen Wandel. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.02.26 - 20:00
|
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery (24/7 Wall St.)
|
|
|
As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock's all-time high. Retail sentiment has turned decisively bullish following the company's Q4 2025 earnings beat, with Reddit's sentiment score climbing from neutral (57.3) to bullish (65.7) over the past week. The catalyst? Eli Lilly overdelivered on ... Why Eli Lilly's $1 Billion AI Bet Could Reshape Drug Discovery
The post Why Eli Lilly's $1 Billion AI Bet Could Reshape Drug Discovery appeared first on 24/7 Wall St.....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
